- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06623838
An Evolutionarily Informed Conceptualization of Personality Pathology (EIC-PP)
An Evolutionarily Informed Conceptualization of Personality Pathology: A Cross-cultural Acceptability and Reliability Study
The purpose of this study is to explore the reliability of a new evolutionarily-informed model for conceptualizing personality pathology. In a preliminary phase prior to the present study we investigated reliability by comparing how therapist pairs conceptualized and assessed the same patient and how therapists and patients assessed the acceptability of the model.
In this new study we want to confirm that the validity data initially collected are valid across cultures and nations.
Therefore, psychology students (n=110) from 5 countries (China, Italy, Poland, Spain, United States) will participate in a specific training on the model and then apply the model on transcripts of the first two sessions and on assessment reports and two supervisors will evaluate the inter-rater reliability and acceptability in using the model on the same patients.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study aims to investigate the cross-cultural validity of a model of assessment and conceptualization of personality disorders. Given the importance of cultural, social and health conditions in the development and maintenance of these disorders, the model will be tested in 5 different countries. This study follows two previous researches that preliminarily explored the feasibility and reliability of the model in couples of Italian patients and therapists (a detailed description of the previous studies is available in the IPD). Below is a brief description of the project registered here:
- Sample (n=110): China (n=22), Italy (n=22), Poland (n=22), Spain (n=22), United States (n=22).
- Primary goal: Interview to assess perceived utility of conceptualization in the whole samples, and then comparing different cultural backgrounds to assess cross-cultural reliability.
- Secondary goals: Scoring in adherence of students by supervisors (same scoring system as in Research 1) to compare Intra Class Correlation within and between national sub-groups.
- Procedure: All participants will access specific online sessions, one for each country sub-group. The first session will correspond to access to a presentation of the theoretical background of the conceptualization model (1 hour in recorded format that participants can access independently). The second session will correspond to an experiential training in which the model will be presented in detail with various clinical cases and a first exercise on the use of this model will be conducted (2.5 hours in live format with all participants simultaneously). The third session will instead be aimed at applying the model on a case that will be presented to all participants and will correspond to a transcript of the two initial sessions and a report on the results of the questionnaires (0.5 hour in live format that participants can access independently). The fourth session will be accessed by some participants (n= 5 per country) and will correspond to a structured interview conducted by a researcher on the acceptability and usefulness of the model (live format that participants can access independently).
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Simone Cheli, PhD
- Phone Number: +39 055679037
- Email: simone.cheli@tagesonlus.org
Study Contact Backup
- Name: Alessia Saini, PsyD
- Phone Number: +39 055679037
- Email: alessia.saini@tagesonlus.org
Study Locations
-
-
-
Florence, Italy, 50137
- Recruiting
- Tages Onlus
-
Principal Investigator:
- Simone Cheli, PhD
-
Contact:
- Veronica Cavalletti
- Phone Number: +39055679037
- Email: veroica.cavalletti@tagesonlus.org
-
Contact:
- Alessia Saini
- Phone Number: +39055679037
- Email: alessia.saini@tagesonlus.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Undergraduate students in their final year
- Recently graduated students.
Exclusion Criteria:
- having left the university program during the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Spanish group
Group/Cohort Description: 22 students in MA in clinical psychology performing the evolutionarily informed case conceptualization.
|
Case conceptualization of personality functioning of a few transcripts of initial sessions and report of psychometric measures of patients diagnosed with personality disorder.
|
|
Polish group
Group/Cohort Description: 22 students in MA in clinical psychology performing the evolutionarily informed case conceptualization.
|
Case conceptualization of personality functioning of a few transcripts of initial sessions and report of psychometric measures of patients diagnosed with personality disorder.
|
|
Chinese group
Group/Cohort Description: 22 students in MA in clinical psychology performing the evolutionarily informed case conceptualization.
|
Case conceptualization of personality functioning of a few transcripts of initial sessions and report of psychometric measures of patients diagnosed with personality disorder.
|
|
Italian group
Group/Cohort Description: 22 students in MA in clinical psychology performing the evolutionarily informed case conceptualization.
|
Case conceptualization of personality functioning of a few transcripts of initial sessions and report of psychometric measures of patients diagnosed with personality disorder.
|
|
American group
Group/Cohort Description: 22 students in MA in clinical psychology performing the evolutionarily informed case conceptualization.
|
Case conceptualization of personality functioning of a few transcripts of initial sessions and report of psychometric measures of patients diagnosed with personality disorder.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cross-cultural inter-rater reliabilitt
Time Frame: From the enrollment to the end of the end of the diagnostic procedure that last 1 hours and will be performed within 1 month from the recruitment.
|
Inter-rater reliability of adherence to the case conceptualization within any single group will be compared with the Italian group where the diagnostic procedure was initially validated to confirm that there are no differences in reliability between Italian group and the other groups.
Inter-rater reliability will be scored as kappa values and intraclass correlation coefficients.
|
From the enrollment to the end of the end of the diagnostic procedure that last 1 hours and will be performed within 1 month from the recruitment.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Cheli S, Cavalletti V, Lysaker PH, Dimaggio G, Petrocchi N, Chiarello F, Enzo C, Velicogna F, Mancini F, Goldzweig G. A pilot randomized controlled trial comparing a novel compassion and metacognition approach for schizotypal personality disorder with a combination of cognitive therapy and psychopharmacological treatment. BMC Psychiatry. 2023 Feb 20;23(1):113. doi: 10.1186/s12888-023-04610-5.
- Cheli S, Goldzweig G, Chiarello F, Cavalletti V. Evolutionary systems therapy for paranoid personality disorder: A seven cases series. Bull Menninger Clin. 2024 Winter;88(1):61-80. doi: 10.1521/bumc.2024.88.1.61.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EIC-PP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Description of research, statistical plan and dataset will be published on OSF. Description of research and statistical plan are available, whereas dataset at the end of the data collection (between January and March, 2025).
To access OSF files: https://osf.io/hnyz6/
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Study Data/Documents
-
Study Protocol
Information identifier: HNYZ6
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.